Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

TCR engagement negatively affects CD8 but not CD4 CAR T cell expansion and leukemic clearance.

Yang Y, Kohler ME, Chien CD, Sauter CT, Jacoby E, Yan C, Hu Y, Wanhainen K, Qin H, Fry TJ.

Sci Transl Med. 2017 Nov 22;9(417). pii: eaag1209. doi: 10.1126/scitranslmed.aag1209.

PMID:
29167392
2.

New interleukin-15 superagonist (IL-15SA) significantly enhances graft-versus-tumor activity.

Bailey CP, Budak-Alpdogan T, Sauter CT, Panis MM, Buyukgoz C, Jeng EK, Wong HC, Flomenberg N, Alpdogan O.

Oncotarget. 2017 Jul 4;8(27):44366-44378. doi: 10.18632/oncotarget.17875.

3.

Interleukin-15 administration increases graft-versus-tumor activity in recipients of haploidentical hematopoietic SCT.

Sauter CT, Bailey CP, Panis MM, Biswas CS, Budak-Alpdogan T, Durham A, Flomenberg N, Alpdogan O.

Bone Marrow Transplant. 2013 Sep;48(9):1237-42. doi: 10.1038/bmt.2013.47. Epub 2013 Apr 29.

PMID:
23624821
4.

Haploidentical hematopoietic SCT increases graft-versus-tumor effect against renal cell carcinoma.

Budak-Alpdogan T, Sauter CT, Bailey CP, Biswas CS, Panis MM, Civriz S, Flomenberg N, Alpdogan O.

Bone Marrow Transplant. 2013 Aug;48(8):1084-90. doi: 10.1038/bmt.2013.9. Epub 2013 Feb 25.

PMID:
23435516
5.

Double haploidentical hematopoietic stem cell transplantation results in successful engraftment of bone marrow from both donors without graft-versus-host or graft-versus-graft effects.

Biswas CS, Sauter CT, Bailey CP, Rittenberg D, Luo X, Panis MM, Budak-Alpdogan T, Grosso D, Flomenberg N, Alpdogan O.

Biol Blood Marrow Transplant. 2012 Dec;18(12):1808-18. doi: 10.1016/j.bbmt.2012.09.012. Epub 2012 Oct 16.

Supplemental Content

Loading ...
Support Center